OnQuality’s chief medical officer and co-founder Hong Tang discusses the firm’s pipeline of cancer supportive care drugs. The oncology space is one of the largest hotbeds for drug development and innovation, and in the past few decades, a spate of…
Covaxin commences Covid-19 vaccine clinical trials in children
On Tuesday, the All India Institute of Medical Sciences (AIIMS) in Patna started clinical trials of India’s homegrown Covid-19 vaccine Covaxin in children between the ages of two to 18 years old. The vaccine, developed by Hyderabad-based Bharat Biotech in…
Pfizer advances clinical trials for 5- to 11-year-olds at lower doses
The study will examine vaccine safety, efficacy and immunity at lower doses. Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical company announced Tuesday. Based on safety, efficacy and…
Covid-19 vaccine patch outshines injectable jab in pre-clinical study
Vaxxas, an Australian clinical-stage biotechnology firm spun out of the University of Queensland, has announced promising results from pre-clinical trials into its novel high-density microarray patch (HD-MAP) for vaccination against Covid-19. A novel SARS-CoV-2 spike subunit vaccine was dry-coated onto…
US eager to involve Indian investigators in clinical trials on Covid: Fauci
Dr Anthony Fauci said his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of Covid-19 therapeutics America’s top infectious disease specialist Dr Anthony Fauci on Thursday said his country is eager…
Link Health and George Clinical to establish clinical development company
Guangzhou Link Health Pharma and George Clinical have signed a term sheet to enter a strategic agreement to launch a clinical development company to deliver trials. The new independent joint venture company called Link-George Clinical Research will deliver clinical trials…
Technology Innovations Most Likely to Carry Over to Postpandemic Era, Poll Shows
As clinical trial professionals prepare for postpandemic operations, they see technology adoptions and hybrid protocol designs as the innovations most likely to be continued after the crisis ends. “Anyone watching the clinical trial industry over the past year can see…
Another big CRO deal has landed as Thermo Fisher acquires PPD for $17.4B
Consolidation among big CRO players is continuing to churn. Following a Wednesday afternoon report from the Wall Street Journal saying a deal was close, Thermo Fisher has announced plans to acquire PPD for $17.4 billion. WSJ had reported that the…
FibroGen Plunges on Murky Data Clarification for CKD Drug Roxadustat
Shares of FibroGen were crashing this morning after the company unsuccessfully attempted to express confidence in the benefit/risk profile of its anemia drug, Roxadustat. This comes ahead of the U.S. Food and Drug Administration’s review of the company’s New Drug Application…
AzurRx BioPharma begins trial of niclosamide tablets for Covid-19
AzurRx BioPharma has started its Phase II clinical trial to evaluate micronised oral niclosamide tablets, known as FW-1022, in patients with Covid-19 gastrointestinal (GI) infection. Patient enrolment for the Phase II two-part, two-arm, placebo-controlled RESERVOIR clinical trial is expected to…
